Functional analysis of miR-101-3p and Rap1b involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis

Biochemistry and Cell Biology

Volumn 92, Issue 2, 2014, Pages 152-162

  Sheng, Yanrui ^a   Ding, Shijia ^a   Chen, Ke ^a   Chen, Juan ^a   Wang, Sen ^a   Zou, Chengcheng ^a   Zhang, Jingnan ^a   Cao, Yiyi ^a   Huang, Ailong ^a   Tang, Hua ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Hepatitis B virus (HBV); Hepatocellular carcinoma (HCC); MicroRNA 101 3p; Ras associated protein 1 b (Rap1b)

Indexed keywords

CELL DEATH; CELL PROLIFERATION; RNA;

BIOLOGICAL PROPERTIES; HEPATITIS B VIRUS; HEPATOCELLULAR CARCINOMA; MICRORNA-101-3P; OVER-EXPRESSION; POTENTIAL EFFECTS; PROMOTER ACTIVITIES; RAS-ASSOCIATED PROTEIN-1 B (RAP1B);

VIRUSES;

MICRORNA; MICRORNA 101 3P; PROTEIN; RAS ASSOCIATED PROTEIN 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL MIGRATION; CELL STRAIN HEPG2; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LUCIFERASE ASSAY; NONHUMAN; PROMOTER REGION; PROTEIN TARGETING; UPREGULATION;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MICRORNAS; PROMOTER REGIONS, GENETIC; RAP GTP-BINDING PROTEINS;

EID: 84898071462     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/bcb-2013-0128     Document Type: Article

References (36)

1. Apicelli A.J. Uhlmann E.J. Baldwin R.L. Ding H. Nagy A. Guha A. Gutmann D.H. 2003. Role of the Rap1 GTPase in astrocyte growth regulation. Glia, 42 (3): 225-234. 10.1002/glia.10214. 12673829.
2. Bartel D.P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116 (2): 281-297. 10.1016/S0092-8674(04)00045-5. 14744438.
3. Blum H.E. Spangenberg H.C. 2007. Hepatocellular carcinoma: an update. Arch. Iran. Med. 10 (3): 361-371. 17604475.
4. Bos J.L. 2005. Linking Rap to cell adhesion. Curr. Opin. Cell Biol. 17 (2): 123-128. 10.1016/j.ceb.2005.02.009. 15780587.
5. Bos J.L. De Bruyn K. Enserink J. Kuiperij B. Rangarajan S. Rehmann H. et al 2003. The role of Rap 1 in integrin-mediated cell adhesion. Biochem. Soc. Trans. 31 (1): 83-86. 12546659.
6. Chan H.L. Sung J.J. 2006. Hepatocellular carcinoma and hepatitis B virus. Semin. Liver Dis. 26: 153-161. 10.1055/s-2006-939753. 16673293.
7. Chrzanowska-Wodnicka M. Kraus A.E. Gale D. White G.C. II Vansluys J. 2008. Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice. Blood, 111: 2647-2656. 10.1182/blood-2007-08- 109710. 17993608.
8. Cullere X. Shaw S.K. Andersson L. Hirahashi J. Luscinskas F.W. Mayadas T.N. 2005. Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Blood, 105: 1950-1955. 10.1182/blood-2004-05-1987. 15374886.
9. Fu X. Tan D. Hou Z. Hu Z. Liu G. 2012. miR-338-3p is down-regulated by hepatitis B virus X and inhibits cell proliferation by targeting the 3′-UTR region of CyclinD1. Int. J. Mol. Sci. 13 (7): 8514-8539. 10.3390/ijms13078514. 22942717.
10. Gao J. Li L. Wu M. Liu M. Xie X. Guo J. et al 2013. MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1. PloS One, 8 (6): e65138. 10.1371/journal.pone.0065138. 23750239.
11. Gao L. Feng Y. Bowers R. Becker-Hapak M. Gardner J. Council L. et al 2006. Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis. Cancer Res. 66 (16): 7880-7888. 10.1158/0008-5472.CAN-06-0254. 16912161.
12. Guo H. Hu X. Ge S. Qian G. Zhang J. 2012. Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation. Int. J. Biochem. Cell Biol. 44 (9): 1465-1472. 10.1016/j.biocel.2012.05.015. 22642900.
13. He X.P. Shao Y. Li X.L. Xu W. Chen G.S. Sun H.H. et al 2012. Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and gastric tumor growth. FEBS J. 279 (22): 4201-4212. 10.1111/febs.12013. 23013439.
14. Huang J. Wang Y. Guo Y. Sun S. 2010. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology, 52 (1): 60-70. 10.1002/hep.23660. 20578129.
15. Ji F. Yang B. Peng X. Ding H. You H. Tien P. 2011. Circulating microRNAs in hepatitis B virus-infected patients. J. Viral Hepat. 18 (7): e242-e251. 10.1111/j.1365-2893.2011.01443.x. 21692939.
16. Jiang J. Gusev Y. Aderca I. Mettler T.A. Nagorney D.M. Brackett D.J. et al 2008. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin. Cancer Res. 14 (2): 419-427. 10.1158/1078-0432.CCR-07-0523. 18223217.
17. Kew M.C. 2010. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol. Biol. (Paris), 58 (4): 273-277. 10.1016/j.patbio.2010.01.005. 15001231.
18. Li R.Y. Chen L.C. Zhang H.Y. Du W.Z. Feng Y. Wang H.B. et al 2013. MiR-139 inhibits Mcl-1 expression and potentiates TMZ-induced apoptosis in Glioma. CNS Neurosci Ther. 19 (7): 477-483. 10.1111/cns.12089. 23551751.
19. Ling Y. Zhu J. Gao L. Liu Y. Zhu C. Li R. et al 2013. The silence of MUC2 mRNA induced by promoter hypermethylation associated with HBV in Hepatocellular Carcinoma. BMC Med. Genet. 14 (1): 14. 10.1186/1471-2350-14-14. 23347460.
20. Liu Y. Zhao J.J. Wang C.M. Li M.Y. Han P. Wang L. et al 2009. Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line. Chin. Med. J. 122: 10-14. 19187610.
21. Livak K.J. Schmittgen T.D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods, 25: 402-408. 10.1006/meth.2001.1262. 11846609.
22. McGlynn K.A. London W.T. 2005. Epidemiology and natural history of hepatocellular carcinoma. Best Pract. Res. Clin. Gastroenterol. 19: 3-23. 10.1016/j.bpg.2004.10.004. 15757802.
23. Parkin D.M. 2006. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer, 118: 3030-3044. 10.1002/ijc.21731. 16404738.
24. Rigoutsos I. 2009. New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites. Cancer Res. 69: 3245-3248. 10.1158/0008-5472.CAN-09-0352. 19351814.
25. Saito Y. Suzuki H. Matsuura M. Sato A. Kasai Y. Yamada K. et al 2011. MicroRNAs in hepatobiliary and pancreatic cancers. Front. Genet. 2: 66. 10.3389/fgene.2011.00066. 22303361.
26. Stork P.J. 2003. Does Rap1 deserve a bad Rap? Trends Biochem. Sci. 28 (5): 267-275. 10.1016/S0968-0004(03)00087-2. 12765839.
27. Su H. Yang J.R. Xu T. Huang J. Xu L. Yuan Y. Zhuang S.M. 2009. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 69 (3): 1135-1142. 10.1158/0008-5472. CAN-08-2886. 19155302.
28. Wang R. Wang H.B. Hao C.J. Cui Y. Han X.C. Hu Y. et al 2012. MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1. PloS One, 7 (10): e46173. 10.1371/journal.pone.0046173. 23071542.
29. Wu D. Huang P. Wang L. Zhou Y. Pan H. Qu P. 2013. MicroRNA-143 inhibits cell migration and invasion by targeting matrix metalloproteinase 13 in prostate cancer. Mol. Med. Rep. 8 (2): 626-630. 10.3892/mmr.2013.1501. 23732700.
30. Xu X. Fan Z. Kang L. Han J. Jiang C. Zheng X. et al 2013. Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J. Clin. Invest. 123 (2): 630-645. 10.1172/JCI64265. 23321675.
31. Yang L. Ma Z. Wang D. Zhao W. Chen L. Wang G. 2010. MicroRNA-602 regulating tumor suppressive gene RASSF1A is over-expressed in hepatitis B virus-infected liver and hepatocellular carcinoma. Cancer Biol. Ther. 9 (10): 803-808. 10.4161/cbt.9.10.11440. 20364114.
32. Yao M. Yao D.F. Bian Y.Z. Zhang C.G. Qiu L.W. Wu W. et al 2011. Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma. Hepatobiliary Pancreat. Dis. Int. 10 (3): 289-294. 10.1016/S1499-3872(11)60048-9. 21669573.
33. Zhang B. Pan X. Cobb G.P. Anderson T.A. 2007. microRNAs as oncogenes and tumor suppressors. Dev. Biol. 302 (1): 1-12. 10.1016/j.ydbio.2006.08.028. 16989803.
34. Zhang M. Zhou S. Zhang L. Zhang J. Cai H. Zhu J. et al 2012. Mir-518b is down-regulated, and involved in cell proliferation and invasion by targeting rap1b in esophageal squamous cell carcinoma. FEBS Lett. 586 (19): 3508-3521. 10.1016/j.febslet.2012.08.007. 22958893.
35. Zhang X. Liu S. Hu T. He Y. Sun S. 2009. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology, 50: 490-499. 10.1002/hep.23008. 19472311.
36. Zhang Z.Z. Liu X. Wang D.Q. Teng M.K. Niu L.W. Huang A.L. Liang Z. 2011. Hepatitis B virus and hepatocellular carcinoma at the miRNA level. World J. Gastroenterol. 17 (28): 3353-3358. 10.3748/wjg.v17.i28.3353. 21876625.